Religare Enterprises Ltd (RELIGARE) — shareholding pattern, promoter holding, financials and share price

About Religare Enterprises Ltd (RELIGARE)

Religare Enterprises Ltd operates in the Investment Company industry, within the Financial Services sector. It trades on the NSE as RELIGARE and on the BSE under scrip code 532915. Its ISIN is INE621H01010.

Religare Enterprise Ltd, incorporated in 1984, is a diversified financial services company with presence all over India, operating through its subsidiaries. The Co. provides loans to SMEs, Affordable Housing Finance, Health Insurance and Retail Broking. REL’s subsidiaries service over 11 lakh clients from over 1,275 locations having presence in more than 400 cities. [1] [2]

Religare Enterprises Limited is a listed holding company and core investment company operating a diversified financial-services platform in India through majority stakes in Care Health Insurance (standalone health insurer), Religare Broking (retail broking and e‑governance), Religare Finvest (SME NBFC) and Religare Housing Development Finance Corporation (affordable housing finance).

The board has approved a strategic demerger to transfer the financial services businesses (lending, broking, ancillary services) into Religare Finvest Limited (RFL), with a 1:1 share swap and planned separate listing of RFL; the scheme targets regulatory approvals and a listing timeline of roughly 15–18 months, aiming to unlock value and simplify capital allocation.

Listed peers in Investment Company: Maharashtra Scooters Ltd, JSW Holdings Ltd, Tsf Investments Ltd, Nalwa Sons Investments Ltd, Kalyani Investment Company Ltd, Elcid Investments Ltd.

Valuation & Returns

10 Jul 2026

At ₹269.6 a share on 10 Jul 2026, Religare Enterprises Ltd (RELIGARE) was valued at a price-to-earnings ratio of 125.66x against an industry P/E of 19.5x and a price-to-book of 3.66x on a book value of ₹73.73 per share as of Mar 2025. Solomo computes return on equity of 2.91% and return on capital employed of 2.01% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
125.66x
Industry P/E
19.5x
P/B
3.66x
EPS (TTM)
₹2.15
Book value / share
₹73.73
ROE
2.91%
ROCE
2.01%
ROA
0.65%
Debt / equity
0.05x
Dividend yield
0%
EBITDA margin
14.68%
52-week range
₹197 – ₹314.15

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Religare Enterprises Ltd (RELIGARE) reported revenue of ₹8,459 crore, net profit of ₹73 crore and earnings per share of ₹2.58. That compares with revenue of ₹7,385 crore and net profit of ₹183 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹2,467 crore and net profit ₹96 crore (consolidated).

Consolidated annual results for Religare Enterprises Ltd (RELIGARE), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)3,2274,6796,2667,3858,459
Net profit (₹ cr)-1,5393,16934718373
EPS (₹)-48.4395.247.063.792.58
Compound annual growth for Religare Enterprises Ltd (RELIGARE). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth-28.33%18.08%-29.39%17.86%
Profit growth----47.23%
Stock price CAGR-1%12%15%-2%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 30.56% of Religare Enterprises Ltd (RELIGARE) (up 0.29 pp QoQ), foreign institutional investors (FII) hold 9.64% and domestic institutional investors (DII) hold 9.33%. Market capitalisation was ₹9,200 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2010.

Largest disclosed public shareholders in Jun 2026: ASHISH DHAWAN 5.24%, CHANDRAKANTA 4.61%, ELLIPSIS PARTNERS LLC 4.45%, MOTILAL OSWAL LARGE AND MIDCAP FUND 4.42%, QUICK TRADING AND INVESTMENT ADVISORS LLP 3.28%, HUF 1.51%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202630.56%-9.64%9.33%69.44%
Mar 202630.27%-7.85%8.52%69.73%
Dec 202526.27%-7.61%9.32%73.73%
Sep 202525.83%-7.8%10.27%74.17%
Jun 202525.83%-8.1%11.62%74.17%
Mar 202525.67%-8.25%11.76%74.33%
Dec 20240%-8.04%13.14%100%
Sep 20240%-8.01%13.43%100%
Every quarter since Sep 2010 Filing data, not investment advice.